Cargando…
Bronchopulmonale Dysplasie (BPD)
OLD VS. NEW BPD: Bronchopulmonary dysplasia (BPD) was described about 50 years ago as a fibroproliferative chronic lung disease in consequence of mechanical ventilation/oxygen exposure in premature infants with respiratory distress syndrome (old BPD). Surfactant therapy with increased survival of ex...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095785/ https://www.ncbi.nlm.nih.gov/pubmed/32226158 http://dx.doi.org/10.1007/s00112-012-2800-8 |
_version_ | 1783510685484843008 |
---|---|
author | Herting, E. |
author_facet | Herting, E. |
author_sort | Herting, E. |
collection | PubMed |
description | OLD VS. NEW BPD: Bronchopulmonary dysplasia (BPD) was described about 50 years ago as a fibroproliferative chronic lung disease in consequence of mechanical ventilation/oxygen exposure in premature infants with respiratory distress syndrome (old BPD). Surfactant therapy with increased survival of extremely premature infants identified a new type of an immaturity-related multisystem disorder that is characterized by a stop/simplification of alveolarisation and lung capillary development (new BPD). THERAPY: To date, mainly symptomatic treatment exists. However, growth factors and stem cell therapy have recently been tested with some success in animal experiments. OUTCOME: Survivors of new BPD may have problems in adult life concerning lung and cardiovascular function, growth and neurosensory and/or motor development. |
format | Online Article Text |
id | pubmed-7095785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70957852020-03-26 Bronchopulmonale Dysplasie (BPD) Herting, E. Monatsschr Kinderheilkd Leitthema OLD VS. NEW BPD: Bronchopulmonary dysplasia (BPD) was described about 50 years ago as a fibroproliferative chronic lung disease in consequence of mechanical ventilation/oxygen exposure in premature infants with respiratory distress syndrome (old BPD). Surfactant therapy with increased survival of extremely premature infants identified a new type of an immaturity-related multisystem disorder that is characterized by a stop/simplification of alveolarisation and lung capillary development (new BPD). THERAPY: To date, mainly symptomatic treatment exists. However, growth factors and stem cell therapy have recently been tested with some success in animal experiments. OUTCOME: Survivors of new BPD may have problems in adult life concerning lung and cardiovascular function, growth and neurosensory and/or motor development. Springer-Verlag 2013-04-28 2013 /pmc/articles/PMC7095785/ /pubmed/32226158 http://dx.doi.org/10.1007/s00112-012-2800-8 Text en © Springer-Verlag Berlin Heidelberg 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Leitthema Herting, E. Bronchopulmonale Dysplasie (BPD) |
title | Bronchopulmonale Dysplasie (BPD) |
title_full | Bronchopulmonale Dysplasie (BPD) |
title_fullStr | Bronchopulmonale Dysplasie (BPD) |
title_full_unstemmed | Bronchopulmonale Dysplasie (BPD) |
title_short | Bronchopulmonale Dysplasie (BPD) |
title_sort | bronchopulmonale dysplasie (bpd) |
topic | Leitthema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095785/ https://www.ncbi.nlm.nih.gov/pubmed/32226158 http://dx.doi.org/10.1007/s00112-012-2800-8 |
work_keys_str_mv | AT hertinge bronchopulmonaledysplasiebpd |